A61K 47/554
The modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or
Official title: {the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}
A61K47/554 (The modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or) appears on 458 US grants and 760 published applications in this corpus.
Search patents in A61K- Granted patents
- 458
- Published applications
- 760
- Assignees
- 326
- Inventors
- 1,241
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 13 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 3 | 1 |
| 2002 | 10 | 18 |
| 2003 | 8 | 11 |
| 2004 | 4 | 12 |
| 2005 | 7 | 25 |
| 2006 | 9 | 26 |
| 2007 | 6 | 17 |
| 2008 | 3 | 14 |
| 2009 | 10 | 15 |
| 2010 | 7 | 22 |
| 2011 | 10 | 17 |
| 2012 | 11 | 17 |
| 2013 | 10 | 27 |
| 2014 | 21 | 24 |
| 2015 | 19 | 30 |
| 2016 | 22 | 37 |
| 2017 | 21 | 33 |
| 2018 | 27 | 37 |
| 2019 | 31 | 45 |
| 2020 | 29 | 44 |
| 2021 | 27 | 50 |
| 2022 | 23 | 53 |
| 2023 | 24 | 47 |
| 2024 | 27 | 62 |
| 2025 | 27 | 48 |
| 2026 | 12 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Blood-brain barrier permeable heteroduplex nucleic acid29 Sep 2026US 12,746,253 B2National University Corporation Tokyo Medical and Dental University
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Semicarbazone-based saponin conjugate18 Aug 2026US 12,708,638 B2Sapreme Technologies B.V.
- Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof11 Aug 2026US 12,702,695 B2Nammi Therapeutics, Inc.
- Lipoprotein-mimicking solid lipid nanoparticles for drug delivery and uses thereof23 Jun 2026US 12,662,673 B2Tionlab Therapeutics
- Combination treatments for cholestasis17 Sep 2026US 2026/0272951 A1The Board of Regents of the University of Oklahoma
- Novel lipid nanoparticle formulations for delivery of nucleic acids17 Sep 2026US 2026/0273033 A1CureVac AG
- Dexamethasone prodrug compositions and uses thereof20 Aug 2026US 2026/0240776 A1Ripple Therapeutics Corporation
- Hendra virus and nipah virus surface glycoprotein peptides, conjugates, and uses thereof20 Aug 2026US 2026/0240982 A1Dana-Farber Cancer Institute, Inc.
- Programmable dna proteolysis target chimeras and methods of their use30 Jul 2026US 2026/0216229 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof518US 5,550,111 ATemple University of the Commonwealth System of Higher Education · 1996
- Cholesteryl modified oligonucleotides341US 4,958,013 ANorthwestern University · 1990
- Steroid modified oligonucleotides301US 5,416,203 ANorthwestern University · 1995
- Method for delivering nucleic acids into cells278US 5,283,185 AMcMaster University · 1994
- Carbohydrate conjugates as delivery agents for oligonucleotides273US 8,106,022 B2Alnylam Pharmaceuticals, Inc. · 2012